Surface Oncology, Inc.
SURF · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$63,586 | -$78,485 | $59,337 | -$54,789 |
| Dep. & Amort. | $1,368 | $1,569 | $1,670 | $1,785 |
| Deferred Tax | $0 | $807 | -$46 | -$763 |
| Stock-Based Comp. | $7,223 | $8,546 | $7,765 | $5,991 |
| Change in WC | -$7,588 | $2,109 | -$42,329 | -$14,252 |
| Other Non-Cash | $3,031 | $3,110 | $3,600 | $1,888 |
| Operating Cash Flow | -$59,552 | -$62,344 | $29,997 | -$60,140 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$497 | -$120 | -$43 | -$1,538 |
| Net Acquisitions | $0 | $0 | $0 | -$16,965 |
| Inv. Purchases | -$40,191 | -$111,632 | -$650 | -$118,347 |
| Inv. Sales/Matur. | $63,445 | $12,500 | $59,000 | $136,850 |
| Other Inv. Act. | $0 | $0 | $0 | $16,965 |
| Investing Cash Flow | $22,757 | -$99,252 | $58,307 | $16,965 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $31,376 | $29,525 | $29,086 | $24 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $31,660 | $42,500 | $40,082 | $7,415 |
| Financing Cash Flow | $31,660 | $42,500 | $40,082 | $7,415 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,135 | -$119,096 | $128,386 | -$35,760 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57,640 | $176,736 | $48,350 | $84,110 |
| End Cash | $52,505 | $57,640 | $176,736 | $48,350 |
| Free Cash Flow | -$60,049 | -$62,464 | $29,954 | -$61,678 |